OncoC4: Funding, Investors & Team (Sep 2026)
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.
OncoC4 has raised $50.0M across 1 funding round on record, the most recent a Series B of $50.0M announced in Oct 2025.
That round is above the $21M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
OncoC4 Company Profile and Key Stats
Latest funding round on record: Oct 2025.
OncoC4 Funding Rounds
OncoC4 Founders and Leadership Team
Contact details for the OncoC4 team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →OncoC4 Funding Compared to Other Biotechnology Startups
OncoC4's latest round of $50.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like OncoC4 in Biotechnology and Rockville
Companies Similar to OncoC4
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other…
Ollin Biosciences operates as a clinical-stage biopharmaceutical company.
Dayra Therapeutics manufactures peptide based medicines.
Chirality Biosciences is a developer of chiral molecule separation technology enabling faster, safer, and…
Bexorg provides a technology platform for central nervous system drug discovery and development.
AeroRx Therapeutics is a biopharmaceutical company that developing proprietary, combination products.
Oligon is an emerging biotechnology company developing a novel class of multimodal RNA therapeutics.
AltrixBio is a pharmaceutical company focused on oral drug that replicates the metabolic success of bariatric…
SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune…
Enlaza Therapeutics is a biotechnology research company.
4TEEN4 Pharmaceuticals develops innovative therapies and biomarkers for diagnosis, prediction, and treatment…
Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and…
OncoC4 Funding FAQs
What does OncoC4 do?
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.
How much funding has OncoC4 raised?
OncoC4 has raised $50.0M across 1 round on record. The most recent is a Series B of $50.0M announced in Oct 2025.
When did OncoC4 last raise funding?
OncoC4's most recent funding round on record is a Series B of $50.0M, announced in Oct 2025.
Who is the CEO of OncoC4?
Yang Liu is listed as CEO at OncoC4.
Where is OncoC4 headquartered?
OncoC4 is based in Rockville, United States.
How many employees does OncoC4 have?
OncoC4 is in the 11-50 employee band.
How does OncoC4's funding compare to other Biotechnology startups?
OncoC4's latest round of $50.0M is above the $21M median round size for Biotechnology companies on FundedIQ across 29 tracked companies over the last two years.
About FundedIQ's OncoC4 Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for OncoC4 is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.